We have read with pleasure the study by Kuzniewicz and Newman (1)
describing an increased bilirubin toxicity expressed as poorer cognitive
outcomes in jaundiced infants with a positive direct antiglobulin test.
Starting from a large, multiracial population of near or at-term neonates,
the interaction was assessed only for a small group of Caucasian infants
with maximal bilirubin ³ 25 mg/dl.
At the time when much remains to be said about bilirubin and neonatal
health especially in the preterm, bilirubin neurotoxicity fails once again
to meet a concentration threshold. Clinicians should seriously realize
that peak bilirubin is not a reliable predictor.
We believe that future research should investigate the relation between
exposure to bilirubin and its toxicity. It is logical to suggest that,
like any drug, there may be an “area under the curve” effect and more
effort is warranted to expand the preliminary evidence in support of this
linkage (2).
Francesco Raimondi, Letizia Capasso, Maria Sellitto, Mariangela De
Rosa
Division of Neonatology , Department of Pediatrics,
Università “Federico II”, Napoli, Italy
1) Kuzniewicz M and Newman TB Interaction of hemolysis and
hyperbilirubinemia on neurodevelopmental outcomes in the Collaborative
Perinatal Project
Pediatrics 2009 ; 123(3): 1045-1050
2) Watchko JF Kernicterus and the molecular mechanisms of bilirubin-
induced CNS injury in newborns
Neuromolecular Medicine 2006; 8: 513-530
Conflict of Interest:
None declared